Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 2 of 2: Calculated dose response metrics - Dataset (ID:20344)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Primary Target | Pathway | GR50 | GRmax | GR_AOC | Death_AUC | GR Hill Coefficient | GEC50 | GR r2 |
---|---|---|---|---|---|---|---|---|---|---|
CAMA-1 | Neratinib | EGFR/HER2 | RTK | 2.8315 | 0.4493 | 0.0703 | 0.0063 | 1.1466 | 7.3732 | 0.99027 |
CAMA-1 | Tivantinib | MET | RTK | 0.27573 | -0.5655 | 0.5259 | 0.2061 | 2.2178 | 0.36921 | 0.99228 |
CAMA-1 | Cediranib | VEGFR/cKIT | RTK | 5.0236 | -0.2923 | 0.1089 | 0.0448 | 2.4671 | 7.8416 | 0.99299 |
CAMA-1 | Cabozantinib | VEGFR2/MET | RTK | 8.7107 | 0.2436 | 0.0342 | 0.0090 | 4.9963 | 10.1282 | 0.97965 |
HCC1428 | Abemaciclib | CDK4/6 | Cell cycle | 0.0097947 | 0.0492 | 0.6359 | 0.0146 | 0.9863 | 0.0062766 | 0.95101 |
HCC1428 | Palbociclib | CDK4/6 | Cell cycle | 0.074657 | 0.2542 | 0.3272 | 0.0037 | 1.4145 | 0.043222 | 0.98733 |
HCC1428 | AZD7762 | CHK1/2 | Cell cycle | 0.39126 | -0.2152 | 0.3761 | 0.0843 | 1.2225 | 0.55117 | 0.98948 |
HCC1428 | Volasertib | PLK | Cell cycle | 0.018634 | -0.0388 | 0.4063 | 0.0917 | 2.1456 | 0.018507 | 0.99276 |
HCC1428 | Dinaciclib | pan CDK | Cell cycle | 0.017078 | -0.6716 | 0.6610 | 0.2408 | 2.9825 | 0.02239 | 0.9979 |
HCC1428 | Cisplatin | Chemo | Chemotherapy | 0.91164 | 0.1223 | 0.2655 | 0.0096 | 1.2004 | 0.80529 | 0.9803 |
HCC1428 | Doxorubicin | Chemo | Chemotherapy | 0.0047408 | -0.7396 | 0.8955 | 0.2242 | 0.5182 | 0.029971 | 0.95944 |
HCC1428 | Taxol | Chemo | Chemotherapy | 0.0086248 | 0.0645 | 0.5066 | 0.2045 | 0.7260 | 0.0074214 | 0.91451 |
HCC1428 | Topotecan | Topo I | Chemotherapy | 0.010613 | -0.3764 | 0.8345 | 0.1405 | 0.6324 | 0.02202 | 0.8529 |
HCC1428 | Etoposide | Topo II | Chemotherapy | 0.21399 | -0.0320 | 0.4009 | 0.0511 | 1.7833 | 0.20625 | 0.98346 |
HCC1428 | Dasatinib | BCR/ABL | MAPK/nRTK | Inf | 0.5784 | 0.2562 | 0.0192 | 0.6681 | 0.040103 | 0.94117 |
HCC1428 | Trametinib | MEK | MAPK/nRTK | Inf | 0.8152 | 0.0767 | 0.0025 | 5.0000 | 0.024413 | 0.9037 |
HCC1428 | Saracatinib | SRC | MAPK/nRTK | Inf | 0.6691 | 0.0697 | 0.0076 | 0.8735 | 1.6565 | 0.94133 |
HCC1428 | ABT-737 | Bcl2/XL | Misc | 4.0616 | 0.2431 | 0.1194 | 0.0716 | 1.0222 | 5.0858 | 0.98165 |
HCC1428 | Vorinostat | HDAC | Misc | 0.83512 | -0.4792 | 0.3399 | 0.1022 | 1.4868 | 1.371 | 0.99679 |
HCC1428 | Luminespib | HSP90 | Misc | 0.0028629 | -0.0043 | 0.6375 | 0.0972 | 5.0000 | 0.0028677 | 0.99886 |
HCC1428 | A-1210477 | Mcl-1 | Misc | Inf | 0.8155 | -0.0207 | 0.0026 | 4.9615 | 5.2131 | 0.71606 |
HCC1428 | Olaparib | PARP | Misc | 0.55326 | 0.1185 | 0.3229 | 0.0089 | 0.8769 | 0.48774 | 0.98952 |
HCC1428 | Bleomycin | Radiation | Misc | 4.2581 | 0.2173 | 0.1780 | 0.0166 | 0.7393 | 18.8191 | 0.91689 |
HCC1428 | Ipatasertib | AKT | PI3K/mTOR | Inf | 0.9911 | -0.0383 | -0.0001 | 0.0000 | Inf | -2.9826 |
HCC1428 | Alpelisib | PI3Ka | PI3K/mTOR | Inf | 0.8530 | 0.0202 | 0.0031 | 0.0000 | Inf | 0.41688 |